Table 2.
Polymorphism | Gene | Chromosome | Reference Allele | Variant Allele | MAF | β Value | P Value |
---|---|---|---|---|---|---|---|
PharmGKB and GWAS Catalog (n = 21)a | |||||||
rs776746 | CYP3A5 | 7 | T | C | 0.17 | −.18 | .0017 |
rs8050894 | VKORC1 | 16 | C | G | 0.23 | .11 | .033 |
rs1800629 | TNF | 6 | G | A | 0.14 | .11 | .068 |
rs17782313 | MC4R | 18 | T | C | 0.24 | −.09 | .073 |
rs12979860 | IFNL4 | 19 | T | C | 0.47 | .04 | .335 |
PharmGKB, not GWAS Catalog (n = 36)a | |||||||
rs11615 | ERCC1 | 19 | G | A | 0.13 | .12 | .08 |
rs2359612 | VKORC1 | 16 | G | A | 0.26 | −.07 | .14 |
rs7997012 | HTR2A | 13 | G | A | 0.05 | − .11 | .23 |
rs1045642 | ABCB1 | 7 | G | A | 0.16 | −.07 | .24 |
rs2298383 | ADORA2A | 22 | C | T | 0.38 | −.05 | .27 |
GWAS Catalog (n = 63 502)a | |||||||
rs7977247 | RIC8B | 12 | C | T | 0.43 | −.18 | 1.1 × 10−6 |
rs10778495 | RFX4 | 12 | G | A | 0.47 | −.19 | 1.7 × 10−6 |
rs10161520 | RFX4 | 12 | T | C | 0.49 | .17 | 1.2 × 10−5 |
rs11113071 | RFX4 | 12 | T | C | 0.45 | .17 | 1.2 × 10−5 |
rs10861637 | RFX4 | 12 | A | G | 0.28 | .19 | 1.3 × 10−5 |
Genome-wide genotype datab (n = 9 074 402)a | |||||||
rs763450 | RFX4 | 12 | A | G | 0.49 | .20 | 6.4 × 10−7 |
rs78277930 | Intergenic | 9 | A | T | 0.05 | −.46 | 6.6 × 10−7 |
rs80098193 | Intergenic | 9 | A | G | 0.05 | −.46 | 6.6 × 10−7 |
rs114384536 | Intergenic | 9 | C | A | 0.05 | −.46 | 6.6 × 10−7 |
rs12310706 | RFX4 | 12 | G | A | 0.45 | −.19 | 7.0 × 10−7 |
Abbreviations: MAF, minor allele frequency; PROBeX, Pharmacokinetics, Resistance, and Outcomes of Bedaquiline in MDR- and XDR-TB.
Parenthetical numbers are numbers of polymorphisms.
All polymorphisms with P values <1.0 × 10−6 are shown.